Asymptomatic Clostridium difficile colonization as a reservoir for Clostridium difficile infection

Expert Review of Anti-Infective Therapy

Volumn 12, Issue 8, 2014, Pages 967-980

  Galdys, Alison L ^a   Curry, Scott R ^a   Harrison, Lee H ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

asymptomatic carriage; Clostridium difficile; Clostridium difficile infection; colonization; epidemiology; molecular epidemiology

Indexed keywords

ASYMPTOMATIC INFECTION; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; CLOSTRIDIUM DIFFICILE INFECTION; DIARRHEA; DISEASE CARRIER; GEOGRAPHIC DISTRIBUTION; HEALTHCARE ASSOCIATED INFECTION; HUMAN; ILEUS; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; LABORATORY DIAGNOSIS; MOLECULAR EPIDEMIOLOGY; NONHUMAN; ONSET AGE; POLYMERASE CHAIN REACTION; PREVALENCE; REVIEW; RIBOTYPING; RISK REDUCTION; TOXIC MEGACOLON; ANIMAL; ENTEROCOLITIS, PSEUDOMEMBRANOUS; GENETICS; GENOTYPING TECHNIQUE; GROWTH, DEVELOPMENT AND AGING; HETEROZYGOTE; ISOLATION AND PURIFICATION; MICROBIOLOGY; PEPTOCLOSTRIDIUM DIFFICILE; TRANSMISSION;

ANIMALS; CARRIER STATE; CLOSTRIDIUM DIFFICILE; DISEASE RESERVOIRS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; GENOTYPING TECHNIQUES; HUMANS;

EID: 84903987886     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.2014.920252     Document Type: Review

References (98)

1. Hall IC, O'Toole E. Intestinal flora in newborn infants with a description of a new pathogenic anaerobe, Bacillus difficilis. Am J Dis Child 1935;49:390-402
2. Smith LD, King EO. Occurrence of Clostridium difficile in infections of man. J Bacteriol 1962;84:65-7
3. Bartlett JG, Chang TW, Gurwith M, et al. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med 1978;298(10):531-4
4. Larson HE, Price AB, Honour P, et al. Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet 1978; 1(8073):1063-6
5. Sorg JA, Sonenshein AL. Bile salts and glycine as cogerminants for Clostridium difficile spores. J Bacteriol 2008;190(7):2505-12
6. Banno Y, Kobayashi T, Kono H, et al. Biochemical characterization and biologic actions of two toxins (D-1 and D-2) from Clostridium difficile. Rev Infect Dis 1984; 6(Suppl 1)):S11-20
7. Voth DE, Ballard JD. Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 2005;18(2): 247-63
8. Muto CA, Pokrywka M, Shutt K, et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 2005;26(3): 273-80
9. Dallal RM, Harbrecht BG, Boujoukas AJ, et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 2002; 235(3):363-72
10. Kuehne SA, Collery MM, Kelly ML, et al. Importance of toxin A, toxin B, and CDT in virulence of an epidemic Clostridium difficile strain. J Infect Dis 2014;209(1): 83-6
11. Shim JK, Johnson S, Samore MH, et al. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet 1998; 351(9103):633-6
12. Freeman J, Bauer MP, Baines SD, et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 2010;23(3):529-49
13. Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2013. Availablefrom:www.cdc.gov/ drugresistance/threat- report-2013/pdf/arthreats- 2013-508.pdf [Last accessed 16 September 2013]
14. Barbut F, Petit JC. Epidemiology of Clostridium difficile-associated infections. Clin Microbiol Infect 2001;7(8):405-10
15. Magill SS, Edwards JR, Bamberg W, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med 2014;370(13):1198-208
16. Kim J, Smathers SA, Prasad P, et al. Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006. Pediatrics 2008;122(6):1266-70
17. Dubberke E. Clostridium difficile infection: the scope of the problem. J Hosp Med 2012;7(Suppl 3):S1-4
18. Gerding DN, Muto CA, Owens RC Jr. Measures to control and prevent Clostridium difficile infection. Clin Infect Dis 2008;46(Suppl 1):S43-9
19. Muto CA, Blank MK, Marsh JW, et al. Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach. Clin Infect Dis 2007;45(10):1266-73
20. Talpaert MJ, Gopal Rao G, Cooper BS, et al. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. J Antimicrob Chemother 2011; 66(9):2168-74
21. Lucado JG, Gould C, Elixhauser A. Clostridium difficile infections (CDI) in hospital stays, 2009. Healthcare cost and utilization project; Rockville, MD, USA: 2012
22. England PH. Quarterly analyses: mandatory MRSA, MSSA, and E. coli Bacteremia and CDI in England (up to July-September 2013). Public Health England; 2013
23. McFarland LV, Mulligan ME, Kwok RY, et al. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989; 320(4):204-10
24. Curry SR, Muto CA, Schlackman JL, et al. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission. Clin Infect Dis 2013;57(8):1094-102
25. al Saif N, Brazier JS. The distribution of Clostridium difficile in the environment of South Wales. J Med Microbiol 1996;45(2): 133-7
26. Zidaric V, Beigot S, Lapajne S, et al. The occurrence and high diversity of Clostridium difficile genotypes in rivers. Anaerobe 2010;16(4):371-5
27. Curry SR, Marsh JW, Schlackman JL, et al. Prevalence of Clostridium difficile in uncooked ground meat products from Pittsburgh, Pennsylvania. Appl Environ Microbiol 2012;78(12):4183-6
28. Rodriguez-Palacios A, Staempfli HR, Duffield T, et al. Clostridium difficile in retail ground meat, Canada. Emerg Infect Dis 2007;13(3):485-7
29. Bouttier S, Barc MC, Felix B, et al. Clostridium difficile in ground meat, France. Emerg Infect Dis 2010;16(4):733-5
30. Songer JG, Trinh HT, Killgore GE, et al. Clostridium difficile in retail meat products, USA, 2007. Emerg Infect Dis 2009;15(5): 819-21
31. Schneeberg A, Rupnik M, Neubauer H, et al. Prevalence and distribution of Clostridium difficile PCR ribotypes in cats and dogs from animal shelters in Thuringia, Germany. Anaerobe 2012;18(5):484-8
32. Walker AS, Eyre DW, Wyllie DH, et al. Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing. PLoS Med 2012;9(2): e1001172
33. Eyre DW, Cule ML, Wilson DJ, et al. Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med 2013;369(13):1195-205
34. Clabots CR, Johnson S, Olson MM, et al. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis 1992;166(3):561-7
35. Kyne L, Warny M, Qamar A, et al. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000; 342(6):390-7
36. Mulligan ME, Miller SD, McFarland LV, et al. Elevated levels of serum immunoglobulins in asymptomatic carriers of Clostridium difficile. Clin Infect Dis 1993;16 Suppl 4:S239-44
37. Sanchez-Hurtado K, Corretge M, Mutlu E, et al. Systemic antibody response to Clostridium difficile in colonized patients with and without symptoms and matched controls. J Med Microbiol 2008;57(Pt 6): 717-24
38. Finegold SM. Letter: fecal bacterial flora and clindamycin-associated colitis. Gastroenterology 1976;70(5 PT.1):822-3
39. Thibault A, Miller MA, Gaese C. Risk factors for the development of Clostridium difficile-associated diarrhea during a hospital outbreak. Infect Control Hosp Epidemiol 1991;12(6):345-8
40. Fekety R, Silva J, Browne RA, et al. Clindamycin-induced colitis. Am J Clin Nutr 1979;32(1):244-50
41. Bartlett JG, Onderdonk AB, Cisneros RL, et al. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis 1977;136(5):701-5
42. Razaq N, Sambol S, Nagaro K, et al. Infection of hamsters with historical and epidemic BI types of Clostridium difficile. J Infect Dis 2007;196(12):1813-19
43. Chen X, Katchar K, Goldsmith JD, et al. A mouse model of Clostridium difficile-associated disease. Gastroenterology 2008;135(6):1984-92
44. Rea MC, Dobson A, O'Sullivan O, et al. Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon. Proc Natl Acad Sci USA 2011; 108(Suppl 1):4639-44
45. Chang JY, Antonopoulos DA, Kalra et al. Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis 2008;197(3):435-8
46. Giel JL, Sorg JA, Sonenshein AL, Zhu J. Metabolism of bile salts in mice influences spore germination in Clostridium difficile. PLoS One 2010;5(1):e8740
47. Chang DE, Smalley DJ, Tucker DL, et al. Carbon nutrition of Escherichia coli in the mouse intestine. Proc Natl Acad Sci USA 2004;101(19):7427-32
48. Leatham MP, Banerjee S, Autieri SM, et al. Precolonized human commensal Escherichia coli strains serve as a barrier to E. coli O157:H7 growth in the streptomycin-treated mouse intestine. Infect Immun 2009;77(7):2876-86
49. Rea MC, Sit CS, Clayton E, et al. Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. Proc Natl Acad Sci USA 2010;107(20):9352-7
50. van Nood E, Dijkgraaf MG, Keller JJ. Duodenal infusion of feces for recurrent Clostridium difficile. N Engl J Med 2013; 368(22):2145
51. Chang TW, Sullivan NM, Wilkins TD. Insusceptibility of fetal intestinal mucosa and fetal cells to Clostridium difficile toxins. Zhongguo Yao Li Xue Bao 1986;7(5): 448-53
52. Baban ST, Kuehne SA, Barketi-Klai A, et al. The role of flagella in Clostridium difficile pathogenesis: comparison between a non-epidemic and an epidemic strain. PLoS One 2013;8(9):e73026
53. Pechine S, Hennequin C, Boursier C, et al. Immunization using GroEL decreases Clostridium difficile intestinal colonization. PloS One 2013;8(11):e81112
54. Barketi-Klai A, Hoys S, Lambert-Bordes S, et al. Role of fibronectin-binding protein A in Clostridium difficile intestinal colonization. J Med Microbiol 2011; 60(Pt 8):1155-61
55. Merrigan MM, Venugopal A, Roxas JL, et al. Surface-layer protein A (SlpA) is a major contributor to host-cell adherence of Clostridium difficile. PLoS One 2013;8(11): e78404
56. Dingle KE, Didelot X, Ansari MA, et al. Recombinational switching of the Clostridium difficile S-layer and a novel glycosylation gene cluster revealed by large-scale whole-genome sequencing. J Infect Dis 2013;207(4):675-86
57. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010;31(5):431-55
58. Debast SB, Bauer MP, Kuijper EJ. The C. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): update of the treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect 2014;20(Suppl 2):1-26
59. Galdys A, Nelson J, Shutt K, et al. Prevalence and duration of asymptomatic carriage of Clostridium difficile among healthy subjects in Pittsburgh, Pennsylvania. J Clin Microbiol 2014;In press
60. Dubberke ER, Han Z, Bobo L, et al. Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections. J Clin Microbiol 2011;49(8):2887-93
61. Loo VG, Bourgault AM, Poirier L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 2011;365(18):1693-703
62. Riggs MM, Sethi AK, Zabarsky TF, et al. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis 2007;45(8):992-8
63. Bolton RP, Tait SK, Dear PR, et al. Asymptomatic neonatal colonisation by Clostridium difficile. Arch Dis Child 1984; 59(5):466-72
64. Larson HE, Barclay FE, Honour P, et al. Epidemiology of Clostridium difficile in infants. J Infect Dis 1982;146(6):727-33
65. Malamou-Ladas H, O'Farrell S, Nash JQ, et al. Isolation of Clostridium difficile from patients and the environment of hospital wards. J Clin Pathol 1983;36(1):88-92
66. Rousseau C, Lemee L, Le Monnier A, et al. Prevalence and diversity of Clostridium difficile strains in infants. J Med Microbiol 2011;60(Pt 8):1112-18
67. Tullus K, Aronsson B, Marcus S, et al. Intestinal colonization with Clostridium difficile in infants up to 18 months of age. Eur J Clin Microbiol Infect Dis 1989;8(5): 390-3
68. Matsuki S, Ozaki E, Shozu M, et al. Colonization by Clostridium difficile of neonates in a hospital, and infants and children in three day-care facilities of Kanazawa, Japan. Int Microbiol 2005;8(1): 43-8
69. Burgner D, Siarakas S, Eagles G, et al. A prospective study of Clostridium difficile infection and colonization in pediatric oncology patients. Pediatr Infect Dis J 1997;16(12):1131-4
70. Hink T, Burnham CA, Dubberke ER. A systematic evaluation of methods to optimize culture-based recovery of Clostridium difficile from stool specimens. Anaerobe 2013;19:39-43
71. Burnham CA, Carroll KC. Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev 2013; 26(3):604-30
72. Killgore G, Thompson A, Johnson S, et al. Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. J Clin Microbiol 2008;46(2). 431-7
73. Curry SR, Marsh JW, Muto CA, et al. TcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile. J Clin Microbiol 2007;45(1):215-21
74. Rupnik M. Clostridium difficile toxinotyping. Methods Mol Biol 2010;646: 67-76
75. Kuijper EJ, Oudbier JH, Stuifbergen WN, et al. Application of whole-cell DNA restriction endonuclease profiles to the epidemiology of Clostridium difficile-induced diarrhea. J Clin Microbiol 1987;25(4):751-3
76. Stubbs SL, Brazier JS, O'Neill GL, et al. PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 1999;37(2):461-3
77. Clabots CR, Johnson S, Bettin KM, et al. Development of a rapid and efficient restriction endonuclease analysis typing system for Clostridium difficile and correlation with other typing systems. J Clin Microbiol 1993;31(7):1870-5
78. Knetsch CW, Lawley TD, Hensgens MP, et al. Current application and future perspectives of molecular typing methods to study Clostridium difficile infections. Euro Surveill 2013;18(4):20381
79. Dingle KE, Griffiths D, Didelot X, et al. Clinical Clostridium difficile: clonality and pathogenicity locus diversity. PLoS One 2011;6(5):e19993
80. Marsh JW, O'Leary MM, Shutt KA, et al. Multilocus variable-number tandem-repeat analysis for investigation of Clostridium difficile transmission in Hospitals. J Clin Microbiol 2006;44(7):2558-66
81. Marsh JW, O'Leary MM, Shutt KA, et al. Multilocus variable-number tandem-repeat analysis and multilocus sequence typing reveal genetic relationships among Clostridium difficile isolates genotyped by restriction endonuclease analysis. J Clin Microbiol 2010;48(2):412-18
82. Eyre DW, Fawley WN, Best EL, et al. Comparison of multilocus variable number tandem repeat analysis and whole genome sequencing for investigation of Clostridium difficile transmission. J Clin Microbiol 2013;51(12):4141-9
83. Samore MH, Venkataraman L, DeGirolami PC, et al. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med 1996;100(1): 32-40
84. Eyre DW, Griffiths D, Vaughan A, et al. Asymptomatic Clostridium difficile colonisation and onward transmission. PLoS One 2013;8(11):e78445
85. Stoesser NE, Martin J, Mawer D, et al. Risk factors for Clostridium difficile acquisition in infants: importance of study design. Clin Infect Dis 2013;56(11):1680-1
86. Stoesser N, Crook DW, Fung R, et al. Molecular epidemiology of Clostridium difficile strains in children compared with that of strains circulating in adults with Clostridium difficile-associated infection. J Clin Microbiol 2011;49(11):3994-6
87. Lanzas C, Dubberke ER, Lu Z, et al. Epidemiological model for Clostridium difficile transmission in healthcare settings. Infect Control Hosp Epidemiol 2011;32(6): 553-61
88. Yakob L, Riley TV, Paterson DL, et al. Clostridium difficile exposure as an insidious source of infection in healthcare settings: an epidemiological model. BMC Infect Dis 2013;13(1):376
89. Gerding DN, Olson MM, Peterson LR, et al. Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study. Arch Intern Med 1986;146(1):95-100
90. Johnson S, Clabots CR, Linn FV, et al. Nosocomial Clostridium difficile colonisation and disease. Lancet 1990; 336(8707):97-100
91. Samore MH, DeGirolami PC, Tlucko A, et al. Clostridium difficile colonization and diarrhea at a tertiary care hospital. Clin Infect Dis 1994;18(2):181-7
92. Marciniak C, Chen D, Stein AC, et al. Prevalence of Clostridium difficile colonization at admission to rehabilitation. Arch Phys Med Rehabil 2006;87(8): 1086-90
93. Guerrero DM, Becker JC, Eckstein EC, et al. Asymptomatic carriage of toxigenic Clostridium difficile by hospitalized patients. J Hosp Infect 2013;85(2):155-8
94. Leekha S, Aronhalt KC, Sloan LM, et al. Asymptomatic Clostridium difficile colonization in a tertiary care hospital: admission prevalence and risk factors. Am J Infect Control 2013;41(5):390-3
95. Nakamura S, Mikawa M, Nakashio S, et al. Isolation of Clostridium difficile from the feces and the antibody in sera of young and elderly adults. Microbiol Immunol 1981; 25(4):345-51
96. Kato H, Kita H, Karasawa T, et al. Colonisation and transmission of Clostridium difficile in healthy individuals examined by PCR ribotyping and pulsed-field gel electrophoresis. J Med Microbiol 2001;50(8):720-7
97. Ozaki E, Kato H, Kita H, et al. Clostridium difficile colonization in healthy adults: transient colonization and correlation with enterococcal colonization. J Med Microbiol 2004;53(Pt 2):167-72
98. Miyajima F, Roberts P, Swale A, et al. Characterisation and carriage ratio of Clostridium difficile strains isolated from a community-dwelling elderly population in the United Kingdom. PLoS One 2011;6(8): e22804